相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CDK9: A key player in cancer and other diseases
Lia Carolina Franco et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
Calla M. Olson et al.
NATURE CHEMICAL BIOLOGY (2018)
Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II
Huasong Lu et al.
NATURE (2018)
Inhibitors of cyclin-dependent kinases as cancer therapeutics
Steven R. Whittaker et al.
PHARMACOLOGY & THERAPEUTICS (2017)
CDK9 is a prognostic marker and therapeutic target in pancreatic cancer
Anna-Laura Kretz et al.
TUMOR BIOLOGY (2017)
Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy
Akane Inoue-Yamauchi et al.
NATURE COMMUNICATIONS (2017)
Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma
Johannes Braegelmann et al.
CELL REPORTS (2017)
CDK9-dependent RNA polymerase II pausing controls transcription initiation
Saskia Gressel et al.
ELIFE (2017)
Overview of CDK9 as a target in cancer research
Fatima Morales et al.
CELL CYCLE (2016)
Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
Peng Wu et al.
DRUG DISCOVERY TODAY (2016)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Ryan D. Cassaday et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Three-Dimensional Cell Culture: A Breakthrough in Vivo
Delphine Antoni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Richard S. Finn et al.
LANCET ONCOLOGY (2015)
Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia
J. Flynn et al.
LEUKEMIA (2015)
CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo
G. P. Gregory et al.
LEUKEMIA (2015)
Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitor
T. K. Albert et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma
Chun-Hao Huang et al.
GENES & DEVELOPMENT (2014)
Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features
Joanna Przybyl et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Systemic treatment of soft-tissue sarcoma -gold standard and novel therapies
Mark Linch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
An introduction to the wound healing assay using live-cell microscopy
James E. N. Jonkman et al.
CELL ADHESION & MIGRATION (2014)
Cyclin-dependent kinases
Marcos Malumbres
GENOME BIOLOGY (2014)
Long-term Treatment Outcomes for Patients With Synovial Sarcoma A 40-year Experience at the University of Florida
Wenyin Shi et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma
Cigall Kadoch et al.
CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
Chromosome Instability Accounts for Reverse Metastatic Outcomes of Pediatric and Adult Synovial Sarcomas
Pauline Lagarde et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The Histone H2B Monoubiquitination Regulatory Pathway Is Required for Differentiation of Multipotent Stem Cells
Oleksandra Karpiuk et al.
MOLECULAR CELL (2012)
Synovial sarcoma in patients under 20 years of age: a multicenter study with a minimum follow-up of 10 years
Bernhard M. Speth et al.
JOURNAL OF CHILDRENS ORTHOPAEDICS (2011)
Cyclin-dependent kinase 9-cyclin K functions in the replication stress response
David S. Yu et al.
EMBO REPORTS (2010)
Comparing Children and Adults With Synovial Sarcoma in the Surveillance, Epidemiology, and End Results Program, 1983 to 2005 An Analysis of 1268 Patients
Iyad Sultan et al.
CANCER (2009)
Role of the cyclin-dependent kinase 9-related pathway in mammalian gene expression and human diseases
Gaetano Romano et al.
CELL CYCLE (2008)
Modeling tissue morphogenesis and cancer in 3D
Kenneth M. Yamada et al.
CELL (2007)
Mammalian cyclin-dependent kinases
M Malumbres et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Characterization of Cdk955 and differential regulation of two Cdk9 isoforms
SM Shore et al.
GENE (2005)
Differential localization and expression of the Cdk9 42k and 55k isoforms
HB Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Overview of sarcomas in the adolescent and young adult population
CE Herzog
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital
EL Spurrell et al.
ANNALS OF ONCOLOGY (2005)
Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1
A Kawai et al.
CANCER LETTERS (2004)
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms
AA Sandberg et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Tumour-cell invasion and migration: Diversity and escape mechanisms
P Friedl et al.
NATURE REVIEWS CANCER (2003)
P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA
X Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Protein kinases - the major drug targets of the twenty-first century?
P Cohen
NATURE REVIEWS DRUG DISCOVERY (2002)
Cyclin-dependent kinases
JW Harper et al.
CHEMICAL REVIEWS (2001)
Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation
DK Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
